免疫检测点抑制剂及其生物标志物在晚期实体肿瘤中的研究进展(5)
[18] Reck M， Rodriguez-Abreu D， Robinson AG， et al. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. N Engl J Med， 2016， 375 (19)：1823-1833.[19] Kwon ED， Drake CG， Scher HI， et al. Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043)：a multicentre ......
您现在查看是摘要页，全文长 3053 字符。